Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years:

Slides:

Advertisements

Similar presentations

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines N. Aliabadi, J.E. Tate, U.D. Parashar Clinical.

Advertisements

Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4–24 years in Turkey M. Cevik, U. Beyazova, A.L. Aral, A. Duyan.

Volume 50, Issue 4, Pages (April 2009)

R. Cavallo Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994 C. Ramière, L. Roche,

Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience M.-C.

Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection D.K.-H. Wong, J. Fung, C.-K. Lee, W.-K.

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines N. Aliabadi, J.E. Tate, U.D. Parashar Clinical.

Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care S. Chevaliez,

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional.

The relationship between tumour necrosis factor-α gene polymorphism and susceptibility and clearance of the persistent hepatitis B virus infection in.

Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study P. Turner, C.

The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional.

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals G. Ippolito Clinical Microbiology and Infection

Virological tools to diagnose and monitor hepatitis C virus infection

Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children N. Agrinier, M. Le Maréchal,

Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective.

Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis: an open-label, randomized, two-centre phase 2a clinical trial

Y. -Y. Su, S. -J. Huang, M. Guo, J. Zhao, H. Yu, W. -G. He, H. -M

Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4–24 years in Turkey M. Cevik, U. Beyazova, A.L. Aral, A. Duyan.

Large increase of rotavirus diarrhoea in the hospital setting associated with emergence of G12 genotype in a highly vaccinated population in Nicaragua

Louis Pasteur, from crystals of life to vaccination

Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years:

J. Zhang, X. -F. Zhang, C. Zhou, Z. -Z. Wang, S. -J. Huang, X. Yao, Z

Dermatitis by Dermatophilus congolensis

Prevalence of Toscana virus antibodies in residents of Croatia

First isolation of Akkermansia muciniphila in a blood-culture sample

Hepatitis C: global epidemiology and strategies for control

Metagenomic analysis of viral genetic diversity in respiratory samples from children with severe acute respiratory infection in China Y. Wang, N. Zhu,

Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup.

Immunogenicity and safety of the 13-valent Pneumococcal Conjugate vaccine in 23- valent pneumococcal polysaccharide vaccine-naive and pre-immunized patients.

High prevalence of early childhood infection by Kaposi's sarcoma-associated herpesvirus in a minority population in China Y. Cao, V. Minhas, X. Tan,

Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients S. Erb, R. Frei,

Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts R. Freeman

Unexpectedly high prevalence of Treponema pallidum infection in the oral cavity of human immunodeficiency virus-infected patients with early syphilis.

Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels B. Sarov, L. Novack, N.

Epidemiology of opportunistic infections in AIDS patients

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Corticosteroids for the treatment of human infection with influenza virus: a systematic review and meta-analysis J.-W. Yang, L.-C. Fan, X.-Y. Miao, B.

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines N. Aliabadi, J.E. Tate, U.D. Parashar Clinical.

C.G. Teo Clinical Microbiology and Infection

S. David, M. Mentasti, J. Parkhill, V.J. Chalker

Symposia and Oral Presentations

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Case–control comparison of bacterial and protozoan microorganisms associated with gastroenteritis: application of molecular detection L.E.S. Bruijnesteijn.

Volume 50, Issue 4, Pages (April 2009)

Survival of hepatitis A and E viruses in soil samples

Y. Huang, B. Yang, W. Li Clinical Microbiology and Infection

Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal.

Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection E. Knops, E. Heger Clinical Microbiology.

Vaccinations against respiratory tract infections at Hajj

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS M. Rybicka,

Clinical Microbiology and Infection

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo

Clostridium difficile toxin testing by National Health Service (NHS) acute Trusts in England: 2008–2013 S.M. Gerver, A.P. Johnson, R.J. Hope Clinical.

J.L. Balcázar Clinical Microbiology and Infection

Acquisition of second-line drug resistance and extensive drug resistance during recent transmission of Mycobacterium tuberculosis in rural China Y. Hu,

CMI editorial report, 2016 Clinical Microbiology and Infection

S.-H. Kung, S.-F. Wang, C.-W. Huang, C.-C. Hsu, H.-F. Liu, J.-Y. Yang

The burden of chikungunya in the Pacific

CMI readers' survey Clinical Microbiology and Infection

Presentation transcript:

Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study F. Ma, J. Yang, G. Kang, Q. Sun, P. Lu, Y. Zhao, Z. Wang, J. Luo, Z. Wang Clinical Microbiology and Infection Volume 22, Issue 9, Pages 811.e9-811.e15 (September 2016) DOI: 10.1016/j.cmi.2016.06.004 Copyright © 2016 Terms and Conditions

Fig. 1 Disposition of participants. HA-L, live attenuated hepatitis A vaccine; HA-I, inactivated hepatitis A vaccine; ECLIA, electrochemiluminescence immunoassay; Anti-HAV IgG, antibodies against hepatitis A virus IgG. Clinical Microbiology and Infection 2016 22, 811.e9-811.e15DOI: (10.1016/j.cmi.2016.06.004) Copyright © 2016 Terms and Conditions

Fig. 2 Vaccine hepatitis A antigen (HAAg) -positive rates in stool samples from participants given live attenuated hepatitis A vaccine (HA-L). Clinical Microbiology and Infection 2016 22, 811.e9-811.e15DOI: (10.1016/j.cmi.2016.06.004) Copyright © 2016 Terms and Conditions